Ted Buchan & Co Takes $8.86 Million Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Ted Buchan & Co acquired a new stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 95,530 shares of the exchange traded fund’s stock, valued at approximately $8,857,000. SPDR S&P Biotech ETF makes up approximately 4.8% of Ted Buchan & Co’s portfolio, making the stock its 5th biggest holding. Ted Buchan & Co owned about 0.13% of SPDR S&P Biotech ETF as of its most recent SEC filing.

Other hedge funds have also recently modified their holdings of the company. Avoro Capital Advisors LLC purchased a new stake in SPDR S&P Biotech ETF in the fourth quarter valued at approximately $396,844,000. Affinity Asset Advisors LLC boosted its position in SPDR S&P Biotech ETF by 105.4% in the 2nd quarter. Affinity Asset Advisors LLC now owns 37,550 shares of the exchange traded fund’s stock worth $3,481,000 after purchasing an additional 737,550 shares in the last quarter. Healthcare of Ontario Pension Plan Trust Fund grew its stake in shares of SPDR S&P Biotech ETF by 30.3% during the 1st quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 3,136,000 shares of the exchange traded fund’s stock worth $297,575,000 after purchasing an additional 730,000 shares during the period. Mirae Asset Securities USA Inc. acquired a new stake in shares of SPDR S&P Biotech ETF during the 2nd quarter worth approximately $55,626,000. Finally, Jane Street Group LLC grew its stake in shares of SPDR S&P Biotech ETF by 68.7% during the 1st quarter. Jane Street Group LLC now owns 961,082 shares of the exchange traded fund’s stock worth $91,197,000 after purchasing an additional 391,333 shares during the period.

SPDR S&P Biotech ETF Price Performance

Shares of NYSEARCA XBI opened at $98.80 on Tuesday. The stock has a market capitalization of $7.53 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a 12 month low of $63.80 and a 12 month high of $103.52. The firm’s 50 day simple moving average is $98.94 and its 200-day simple moving average is $93.97.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.